Aiming to improve the efficiency, economics and scalability so that spent nuclear fuel can be transformed into a valuable energy resource
The 2026 list highlights the pharmaceutical companies, biotechnology firms and CRDMOs are advancing decarbonization, green manufacturing and sustainable operations
Thermo Fisher Scientific and The Michael J. Fox Foundation expand the Parkinson’s Precision Medicine Initiative (PPMI) proteomic data resource
Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing, and streamline development of safer, more effective medicines
The multiplex PCR assay differentiates herpes simplex virus, varicella-zoster virus, and monkeypox virus in a single test
Verdel Instruments and the University of Warwick bring two-dimensional mass spectrometry (2DMS) to benchtop Q-TOF systems, expanding access to advanced molecular analysis
Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient care
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta’s CDx Accelerator Model
University of Nottingham uses Genome Detective to replace slower Sanger-based workflows and complex bioinformatics pipelines
NanoSomiX and Beckman Coulter Diagnostics collaborate to advance EV-based blood tests for neurodegenerative diseases
Enzyme-based method enables DNA-encoded drug libraries to be built under mild, DNA-friendly conditions
Researchers identify post-surgical blood-brain barrier windows that enable targeted nanoparticle delivery against glioblastoma recurrence
LITILIT highlights femtosecond lasers as a PFAS-free alternative for creating water-repellent and functional surfaces
Partnership expands access to advanced net weight filling and capping systems for UK manufacturers
Novogene Europe expands single-cell RNA sequencing services at its Cambridge Omics Centre to support advanced multiomics research
FDA registration represents an important milestone in expanding access to the technology for healthcare professionals in the United States
The team will also discuss evidence strategies for 510(k), De Novo, and PMA programs, as well as SitePath™ site operations function and TrialPathDx™ Clinical Trial Management System
Discover how structured collaboration with a contract development and manufacturing organization (CDMO) supports better early engineering decisions
Siemens Healthineers will unveil innovations designed to optimize strategic impact, along with new research conducted by YouGov
Thermo Fisher’s presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinical needs with reliable, purpose-built diagnostic and workflow solutions
bioMérieux to showcase integrated microbiology, molecular diagnostics, mass spectrometry, and laboratory informatics solutions
G&H will highlight end-to-end diagnostic instrument development, photonics integration, and ISO 13485-certified manufacturing for next-generation IVDs and medical devices
ADLM 2026 to explore diabetes milestones, space diagnostics, Alzheimer’s and Down syndrome linkages, and advances in cancer screening and biomarkers
Low-cost, 3D-printed flow battery from Queen’s University Belfast to support long-duration renewable energy storage
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
